This inventor holds 2 USPTO granted patents. Top assignee: Northwestern University. Active years: 2021-2025.
Company Filing History:
Years Active: 2021-2025
Title: Innovations by Inventor Shaobin Shang
Introduction
Shaobin Shang is a notable inventor based in Evanston, IL (US). He has made significant contributions to the field of vaccine development, holding 2 patents that focus on innovative vaccine compositions.
Latest Patents
Shaobin Shang's latest patents include groundbreaking work on multi-subunit vaccines designed to elicit both MHC- and CD1-restricted T cell responses. These patents provide compositions that comprise a nanocarrier along with a lipid antigen, a peptide antigen, or combinations thereof. The goal of these compositions is to stimulate both CD1-restricted and MHC-restricted T cell responses in subjects. Methods for making and utilizing these subunit vaccine compositions are also detailed in his patents.
Career Highlights
Shaobin Shang is affiliated with Northwestern University, where he continues to advance research in immunology and vaccine technology. His work is pivotal in developing new strategies for effective vaccination.
Collaborations
Some of his notable coworkers include Evan A Scott and Chyung-Ru Wang, who contribute to the collaborative research efforts at Northwestern University.
Conclusion
Shaobin Shang's innovative work in vaccine development exemplifies the importance of research in advancing public health. His contributions are paving the way for new therapeutic strategies in immunology.